Shirakawa R: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{EAGLE | {{EAGLE | ||
|COST= | |COST= Member | ||
|COST WG2= WG2 | |COST WG2= WG2 | ||
|COST WG4= WG4 | |COST WG4= WG4 | ||
Line 18: | Line 18: | ||
{{Labelingperson}} | {{Labelingperson}} | ||
==Participated at== | ==Participated at== | ||
*[[ | ::::* [[IOC115 | IOC115 Schroecken AT]] |
Latest revision as of 11:56, 14 February 2018
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Shirakawa R
MitoPedia topics: EAGLE
COST: Member
COST WG2: WG2
COST WG4: WG4
Name | Shirakawa Ryosuke, |
---|---|
Institution | Hokkaido University
Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine |
Address | Kita-14 Nishi-7, Kita-Ku, 060-8638 |
City | Sapporo |
State/Province | |
Country | Japan |
[email protected] | |
Weblink | |
O2k-Network Lab | JP Sapporo Yokota T |
Labels:
Publications
Published | Reference | |
---|---|---|
Shirakawa 2023 Sci Rep | 2023 | Shirakawa R, Nakajima T, Yoshimura A, Kawahara Y, Orito C, Yamane M, Handa H, Takada S, Furihata T, Fukushima A, Ishimori N, Nakagawa M, Yokota I, Sabe H, Hashino S, Kinugawa S, Yokota T (2023) Enhanced mitochondrial oxidative metabolism in peripheral blood mononuclear cells is associated with fatty liver in obese young adults. https://doi.org/10.1038/s41598-023-32549-w |
Nambu 2021 Cardiovasc Res | 2021 | Nambu H, Takada S, Maekawa S, Matsumoto J, Kakutani N, Furihata T, Shirakawa R, Katayama T, Nakajima T, Yamanashi K, Obata Y, Nakano I, Tsuda M, Saito A, Fukushima A, Yokota T, Nio-Kobayashi J, Yasui H, Higashikawa K, Kuge Y, Anzai T, Sabe H, Kinugawa S (2021) Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance. Cardiovasc Res 117:805-19. |
Furihata 2021 BMC Pharmacol Toxicol | 2021 | Furihata T, Maekawa S, Takada S, Kakutani N, Nambu H, Shirakawa R, Yokota T, Kinugawa S (2021) Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice. BMC Pharmacol Toxicol 22:27. |
Nakajima 2019 Sci Rep | 2019 | Nakajima T, Yokota T, Shingu Y, Yamada A, Iba Y, Ujihira K, Wakasa S, Ooka T, Takada S, Shirakawa R, Katayama T, Furihata T, Fukushima A, Matsuoka R, Nishihara H, Dela F, Nakanishi K, Matsui Y, Kinugawa S (2019) Impaired mitochondrial oxidative phosphorylation capacity in epicardial adipose tissue is associated with decreased concentration of adiponectin and severity of coronary atherosclerosis. Sci Rep 9:3535. |
Shirakawa 2019 Sci Rep | 2019 | Shirakawa R, Yokota T, Nakajima T, Takada S, Yamane M, Furihata T, Maekawa S, Nambu H, Katayama T, Fukushima A, Saito A, Ishimori N, Dela F, Kinugawa S, Anzai T (2019) Mitochondrial reactive oxygen species generation in blood cells is associated with disease severity and exercise intolerance in heart failure patients. Sci Rep 9:14709. |
Nambu 2019 Eur J Pharmacol | 2019 | Nambu H, Takada S, Fukushima A, Matsumoto J, Kakutani N, Maekawa S, Shirakawa R, Nakano I, Furihata T, Katayama T, Yamanashi K, Obata Y, Saito A, Yokota T, Kinugawa S (2019) Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure. Eur J Pharmacol 866:172810. |
Abstracts
Published | Reference | |
---|---|---|
Nakajima 2017 Europ Heart J | 2017 | Mitochondrial dysfunction in epicardial adipose tissue; possible role in progression of coronary artery disease. |